Figure 6
From: A potential primary endpoint for clinical trials in glaucoma neuroprotection
Greyscale maps depicting the frequency distribution of test locations reaching Endpoints A (top) and B (bottom) of right and left eyes for the entire final sample (N = 470 eyes). The legend corresponds to the absolute number of eyes in which a given location reached the endpoint.
